Academic Journal
Q1British Journal of Haematology
About British Journal of Haematology
British Journal of Haematology is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 places it in Q1 with an SJR of 1.455 and an H-index of 220.
Its listed coverage is 1955-2026 and its research categories include Hematology (Q1). The 2025 dataset reports 614 documents and 5068 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Platelet Disorders and Treatments, Hemoglobinopathies and Related Disorders, Chronic Lymphocytic Leukemia Research, Blood groups and transfusion.
Recent Research Articles
Latest publications matched automatically by ISSN.
Hyperdiploid multiple myeloma: A heterogeneous entity requiring refined risk stratification—Insights from chromosome count and cytogenetic abnormalities
Zhao Zeng, Jiao Lu, Jingjing Shang, Hongyin You et al.
2026-09-19 · DOI: 10.1111/bjh.70817Outcomes for post‐transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre UK study
Alexandros Rampotas, Amy A. Kirkwood, Maximillian Brodermann, Nicola Maciocia et al.
2026-09-18 · DOI: 10.1111/bjh.70848Maternal iron status in pregnancy: The liver as an understudied confounder
Christos Zavos
2026-09-18 · DOI: 10.1111/bjh.70853A phase IIa study of the anti‐ PD ‐ L1 antibody avelumab in relapsed/refractory PTCL : The AVAIL ‐T trial
Matthew J. Ahearne, Matthew A. Timmins, Charlotte Gaskell, Aimee Jackson et al.
2026-09-18 · DOI: 10.1111/bjh.70828Interplay between fibroblast growth factor 9 (FGF9) and CD44 underlies 46,XY disorders of sex development in Kruppel‐like factor 1 (KLF‐1)‐E325K‐associated congenital dyserythropoietic anaemia (CDA‐IV)
Yaddanapudi Ravindranath, Douglas B. Craig, Prahlad Parajuli, Shruti Bagla et al.
2026-09-17 · DOI: 10.1111/bjh.70760Patient‐reported symptom burden after chimeric antigen receptor T‐cell therapy
Christina Kazzi, Lauren Melitsis, Daniel Pearce, Miriam Wronski et al.
2026-09-16 · DOI: 10.1111/bjh.70842Pancreatic iron overload as a marker of endocrine complications in transfusion‐dependent thalassaemia: A multicentre study
Antonella Meloni, Laura Pistoia, Filomena Longo, Paolo Ricchi et al.
2026-09-16 · DOI: 10.1111/bjh.70840ICI ‐containing salvage therapy improves outcomes in relapsed/progressive NKTCL after first‐line treatment
Zhichao Li, Wenhao Zhang, Yang Zhu, Yujie Ma et al.
2026-09-16 · DOI: 10.1111/bjh.70841Reply to Correspondence: Leveraging paired germline and somatic analysis to improve the classification of DDX41 variants
Terri Patricia McVeigh, Jamshid S. Khorashad
2026-09-16 · DOI: 10.1111/bjh.70788Independent validation of the International Metabolic Prognostic Index (CAR‐IMPI) in patients with aggressive diffuse large B‐cell lymphoma treated with CAR‐T
Eugenio Galli, Andrea Guarneri, Alessandro Corrente, Francesca Maria Portonera et al.
2026-09-16 · DOI: 10.1111/bjh.70846Reduced‐dose versus standard‐dose total body irradiation before allogeneic haematopoietic stem cell transplantation in adults with acute lymphoblastic leukaemia
Isabella Gruber, Matthias Edinger, Hendrik Poeck, Elisabeth Meedt et al.
2026-09-15 · DOI: 10.1111/bjh.70835Sickle cell anaemia with and without crises: An observational study of pregnancy outcomes
Nathalie Auger, Émilia Mailhot‐Diaferia, Gabriel Côté‐Corriveau, Gilles Paradis et al.
2026-09-14 · DOI: 10.1111/bjh.70837Stroke incidence and phenotype in Saudi patients with sickle cell disease: A longitudinal cohort study
Mohammed Al‐Agha, Fahad Albadr, Aamer Aleem, Farjah H. Algahtani et al.
2026-09-13 · DOI: 10.1111/bjh.70830Parvovirus B19 infections in paediatric sickle cell disease patients: Genotype and hydroxyurea treatment influence disease severity
Matthias Bleeke, Arne Simon, Beate Winkler, Sabine Heine et al.
2026-09-13 · DOI: 10.1111/bjh.70809Optimizing cord blood unit selection to improve survival after single‐unit unrelated cord blood transplantation for adult myelodysplastic syndrome
Takaaki Konuma, Machiko Fujioka, Kyoko Fuse, Tatsuya Suwabe et al.
2026-09-10 · DOI: 10.1111/bjh.70822A pro‐inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation
Catherine B. Ducker, Megan V. Preece, Jeremy Schofield, Charis Pericleous et al.
2026-09-09 · DOI: 10.1111/bjh.70816Response to the Letter to the Editor regarding ‘Evaluating high‐sensitivity troponin levels in patients with sickle cell disease presenting to the emergency department’
Najibah A. Galadanci, Abdelrhman Mohammed, Gerhard Hellemann, Julie Kanter et al.
2026-09-09 · DOI: 10.1111/bjh.70834Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera
Alessandro Costa, Olga Mulas, Federica Pilo, Eleonora Atzeni et al.
2026-09-08 · DOI: 10.1111/bjh.70820Real‐world romiplostim dosing, response and home administration in paediatric immune thrombocytopenia
Emily M. Harris, Caitlin Montcrieff, Rachael F. Grace
2026-09-08 · DOI: 10.1111/bjh.70790Dynamic risk stratification using early CAR ‐T expansion in R/R LBCL treated with axicabtagene ciloleucel
Brydon Panozzo, Samuel Robinson, Adrian G. Minson, Jian Li et al.
2026-09-07 · DOI: 10.1111/bjh.70825Reviews
Community Reviews
Version History
September 8, 2026 at 12:04 am
September 8, 2026